Anna Sandstedt

785 citations

17 papers · 486 indexed · h-index 10

Co-authors: Kristina Carlson Bertil Uggla Cecilia Isaksson Stig Lenhoff Hans Hägglund Birgitta Lauri Anders Österborg Stefan Norin
Topics: Hematopoietic Stem Cell Transplantation (9 papers)Chronic Lymphocytic Leukemia Research (6 papers)Polyomavirus and related diseases (5 papers)
Cited by: Hematology Genetics Pathology and Forensic Medicine
Journals: Blood Journal of Neurology Neurosurgery & Psychiatry Oncotarget
Partner nations: Sweden France Netherlands

In The Last Decade

Anna Sandstedt

17 papers receiving 481 citations

Peers

Countries citing papers authored by Anna Sandstedt

Since Specialization

Citations

This map shows the geographic impact of Anna Sandstedt's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anna Sandstedt with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anna Sandstedt more than expected).

Fields of papers citing papers by Anna Sandstedt

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anna Sandstedt. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anna Sandstedt. The network helps show where Anna Sandstedt may publish in the future.

Co-authorship network of co-authors of Anna Sandstedt

This figure shows the co-authorship network connecting the top 25 collaborators of Anna Sandstedt. A scholar is included among the top collaborators of Anna Sandstedt based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anna Sandstedt. Anna Sandstedt is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

17 of 17 papers shown

#	Work	Indexed citations
1	Cancer incidence in healthy Swedish peripheral blood stem cell donors 2022 ·Bone Marrow Transplantation ·(unknown),(unknown),Jan‐Erik Johansson,(unknown),Per Ljungman,Anna Sandstedt,Hans Hägglund,(unknown)	4
2	High Graft-versus-Host Disease-Free, Relapse/Rejection-Free Survival and Similar Outcome of Related and Unrelated Allogeneic Stem Cell Transplantation for Aplastic Anemia: A Nationwide Swedish Cohort Study 2019 ·Biology of Blood and Marrow Transplantation ·Krista Vaht,Magnus Göransson,Kristina Carlson,Cecilia Isaksson,Stig Lenhoff,Anna Sandstedt,Bertil Uggla,Jacek Winiarski,Per Ljungman,Per‐Ola Andersson,Mats Brune	8
3	First-line therapy in chronic lymphocytic leukemia: a Swedish nation-wide real-world study on 1053 consecutive patients treated between 2007 and 2013 2018 ·Haematologica ·(unknown),(unknown),Hemming Johansson,Jenny Klintman,(unknown),(unknown),Eva Kimby,Stefan Norin,Per‐Ola Andersson,Claes Karlsson,Karin Karlsson,Birgitta Lauri,Mattias Mattsson,Anna Sandstedt,Maria Strandberg,Anders Österborg,Lotta Hansson	28
4	Low response rate to ATG‐based immunosuppressive therapy in very severe aplastic anaemia — A Swedish nationwide cohort study 2018 ·European Journal Of Haematology ·Krista Vaht,Magnus Göransson,Kristina Carlson,Cecilia Isaksson,Stig Lenhoff,Anna Sandstedt,Bertil Uggla,Jacek Winiarski,Per Ljungman,Mats Brune,Per‐Ola Andersson	14
5	Outcome of Patients with Chronic Lymphocytic Leukemia (CLL) Receiving First Line Therapy: A Swedish Nation-Wide Study on 1053 Consecutive Patients Treated between 2007 and 2013 2017 ·Blood ·(unknown),(unknown),Hemming Johansson,Jenny Klintman,(unknown),(unknown),Eva Kimby,Stefan Norin,(unknown),Claes Karlsson,Karin Karlsson,Birgitta Lauri,Mattias Mattsson,Anna Sandstedt,Maria Strandberg,Anders Österborg,Lotta Hansson	1
6	Real-World Results on Ibrutinib in Relapsed/Refractory CLL: A 21-Month Follow-up of 95 Swedish Patients Treated in a Compassionate Use Program 2017 ·Blood ·(unknown),Per‐Ola Andersson,(unknown),Karin Karlsson,Claes Karlsson,Birgitta Lauri,Jeanette Lundin,Mattias Mattsson,Stefan Norin,Anna Sandstedt,Lotta Hansson,Anders Österborg	2
7	Incidence and outcome of acquired aplastic anemia: real-world data from patients diagnosed in Sweden from 2000–2011 2017 ·Haematologica ·Krista Vaht,Magnus Göransson,Kristina Carlson,Cecilia Isaksson,Stig Lenhoff,Anna Sandstedt,Bertil Uggla,Jacek Winiarski,Per Ljungman,Mats Brune,(unknown)	61
8	Short‐term side effects and attitudes towards second donation: A comparison of related and unrelated haematopoietic stem cell donors 2017 ·Journal of Clinical Apheresis ·(unknown),(unknown),(unknown),Anne Fischer‐Nielsen,Eva Haastrup,Dag Heldal,Maija Itälä‐Remes,Jan‐Erik Johansson,Marjut Kauppila,Stig Lenhoff,Per Ljungman,(unknown),Anna Sandstedt,Hans Hägglund	3
9	Successful autologous haematopoietic stem cell transplantation for refractory myasthenia gravis – a case report 2016 ·Neuromuscular Disorders ·Irene Håkansson,Anna Sandstedt,Fredrik Lundin,Håkan Askmark,Ritva Pirskanen,Kristina Carlson,Fredrik Piehl,Hans Hägglund	23
10	High CD3+ and CD34+ peripheral blood stem cell grafts content is associated with increased risk of graft-versus-host disease without beneficial effect on disease control after reduced-intensity conditioning allogeneic transplantation from matched unrelated donors for acute myeloid leukemia — an analysis from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation 2016 ·Oncotarget ·Tomasz Czerw,Myriam Labopin,Christoph Schmid,Jan J. Cornelissen,Patrice Chevallier,Didier Blaise,Jürgen Kuball,Stéphane Vigouroux,Frédéric Garban,Bruno Lioure,Nathalie Fegueux,Laurence Clément,Anna Sandstedt,Johan Maertens,Gaëlle Guillerm,Dominique Bordessoule,Mohamad Mohty,Arnon Nagler	41
11	Real-world results of ibrutinib in patients with relapsed or refractory chronic lymphocytic leukemia: data from 95 consecutive patients treated in a compassionate use program. A study from the Swedish Chronic Lymphocytic Leukemia Group 2016 ·Haematologica ·(unknown),(unknown),Per Andersson,Karin Karlsson,Claes Karlsson,Birgitta Lauri,Jeanette Lundin,Mattias Mattsson,Stefan Norin,Anna Sandstedt,Lotta Hansson,Anders Österborg	76
12	Incidence and Outcome in Aplastic Anemia Diagnosed 2000-2011 - a Nationwide Swedish Registry Study 2016 ·Blood ·Krista Vaht,Magnus Göransson,Kristina Carlson,Cecilia Isaksson,Stig Lenhoff,Anna Sandstedt,Bertil Uggla,Per Ljungman,Mats Brune,Per‐Ola Andersson	1
13	In Vivo Cytochrome P450 3A Isoenzyme Activity and Pharmacokinetics of Imatinib in Relation to Therapeutic Outcome in Patients With Chronic Myeloid Leukemia 2015 ·Therapeutic Drug Monitoring ·Karin Skoglund,Johan Richter,Ulla Olsson‐Strömberg,Jonas Bergquist,(unknown),S. J. Kumari A. Ubhayasekera,Svante Vikingsson,(unknown),Stina Söderlund,Anna Sandstedt,Anders Johnsson,(unknown),(unknown),Staffan Hägg,Curt Peterson,Kourosh Lotfi,Henrik Gréen	10
14	Real-World Results on Ibrutinib in Patients with Relapsed or Refractory Chronic Lymphocytic Leukemia (CLL): Data from 97 Swedish Patients Treated in a Compassionate Use Program 2015 ·Blood ·Lotta Hansson,(unknown),(unknown),(unknown),Karin Karlsson,Claes Karlsson,Birgitta Lauri,Jeanette Lundin,Mattias Mattsson,Stefan Norin,Anna Sandstedt,Anders Österborg	6
15	Autologous haematopoietic stem cell transplantation for aggressive multiple sclerosis: the Swedish experience 2014 ·Journal of Neurology Neurosurgery & Psychiatry ·Joachim Burman,Ellen Iacobaeus,Anders Svenningsson,Jan Lycke,Martin Gunnarsson,Petra Nilsson,Magnus Vrethem,S. Fredrikson,Claes Martin,Anna Sandstedt,Bertil Uggla,Stig Lenhoff,Jan‐Erik Johansson,Cecilia Isaksson,Hans Hägglund,Kristina Carlson,Jan Fagius	118
16	Impact of in vivo T-cell depletion on outcome of AML patients in first CR given peripheral blood stem cells and reduced-intensity conditioning allo-SCT from a HLA-identical sibling donor: a report from the Acute Leukemia Working Party of the European group for Blood and Marrow Transplantation 2014 ·Bone Marrow Transplantation ·F Baron,Myriam Labopin,Didier Blaise,Lucía López‐Corral,S. Vigouroux,Charles Craddock,Michel Attal,Pavel Jindra,Hakan Göker,Gèrard Socié,Patrice Chevallier,Paul Browne,Anna Sandstedt,Rafael F. Duarte,Arnon Nagler,Mohamad Mohty	72
17	Impact of cytogenetics risk on outcome after reduced intensity conditioning allo-SCT from an HLA-identical sibling for patients with AML in first CR: a report from the acute leukemia working party of EBMT 2012 ·Bone Marrow Transplantation ·Patrice Chevallier,Myriam Labopin,Nöel Milpied,Jan J. Cornelissen,Didier Blaise,Eefke Petersen,Anna Sandstedt,Hakan Göker,Gèrard Socié,Vanderson Rocha,Mohamad Mohty,(unknown)	18

About Anna Sandstedt

Anna Sandstedt is a scholar working on Hematology, Transplantation and Genetics, having authored 17 papers that have together received 486 indexed citations. Recurring topics across this work include Hematopoietic Stem Cell Transplantation (9 papers), Chronic Lymphocytic Leukemia Research (6 papers) and Polyomavirus and related diseases (5 papers). The work is most often cited by research in Hematology (284 citations), Genetics (150 citations) and Pathology and Forensic Medicine (197 citations). Anna Sandstedt has collaborated with scholars based in Sweden, France and Netherlands. Frequent co-authors include Kristina Carlson, Bertil Uggla, Cecilia Isaksson, Stig Lenhoff, Hans Hägglund, Birgitta Lauri, Anders Österborg, Stefan Norin, Claes Karlsson and Mattias Mattsson. Their work appears in journals such as Blood, Journal of Neurology Neurosurgery & Psychiatry and Oncotarget.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact